Laurus Labs Q4 Results: Stock falls after revenue miss but margins expand
Published on: April 30, 2026, 3:28 p.m. | Source: CNBC TV18
For the quarter, Laurus Labs' CDMO business saw revenue growth of 20% from last year to ₹589 crore, while its key generics business saw a 1% decline to ₹1,223 crore.
